29-Sept-2026 10:53:10
SYMBIOTECGeneral news
SYMBIOTEC : ESTABLISHMENT INSPECTION REPORT RECEIVED FROM U.S. FDA
• Symbiotec Pharmalab Limited has received the Establishment Inspection Report (EIR) from the U.S. FDA for its manufacturing facility in Pithampur, Madhya Pradesh. • The facility has received a Voluntary Action Indicated (VAI) status. • The inspection was conducted from August 10, 2026 to August 14, 2026.
Symbiotec Pharmalab Ltd
Open attachment